Log In
Print
BCIQ
Print
Print this Print this
 

JR-051

  Manage Alerts
Collapse Summary General Information
Company JCR Pharmaceuticals Co. Ltd.
DescriptionRecombinant human alpha galactosidase A enzyme
Molecular Target Alpha galactosidase A
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentPreclinical
IndicationFabry's disease
Partner

Amicus Therapeutics Inc.; GlaxoSmithKline plc
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today